The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer

Prostate cancer is the most common cancer in men and the second leading cause of cancer-related deaths. The most used biomarker to detect prostate cancer is Prostate Specific Antigen (PSA), whose levels are measured in serum. However, it has been recently established that molecular markers of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Arriaga-Canon, Cristian, De La Rosa-Velázquez, Inti Alberto, González-Barrios, Rodrigo, Montiel-Manríquez, Rogelio, Oliva-Rico, Diego, Jiménez-Trejo, Francisco, Cortés-González, Carlo, Herrera, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945524/
https://www.ncbi.nlm.nih.gov/pubmed/29755696
http://dx.doi.org/10.18632/oncotarget.25038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945524/
https://www.ncbi.nlm.nih.gov/pubmed/29755696
http://dx.doi.org/10.18632/oncotarget.25038

Ejemplares similares